ArticleBMC cancer2025

Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients.

Xin Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.